PDCD1 and melanoma: For example, the dramatic anti-melanoma efficacy of ZD55-IL-24 is merely confined to local tumors, but substantially reduced in distant tumors and extremely lower than anti-PD-1 antibody (Fig. 3b, c, f–k).